BioStem Technologies, Inc. (OTCMKTS:BSEM) Sees Significant Growth in Short Interest

BioStem Technologies, Inc. (OTCMKTS:BSEM) was the recipient of a large growth in short interest in October. As of October 15th, there was short interest totalling 94,100 shares, a growth of 6.2% from the September 30th total of 88,600 shares. Based on an average trading volume of 60,800 shares, the short-interest ratio is currently 1.5 days.

BioStem Technologies Stock Up 6.1 %

BSEM stock opened at 18.00 on Thursday. The company has a 50-day simple moving average of 11.25 and a 200 day simple moving average of 9.82. The company has a market capitalization of $293.18 million, a P/E ratio of 46.15 and a beta of 0.05. BioStem Technologies has a fifty-two week low of 2.26 and a fifty-two week high of 18.75.

BioStem Technologies (OTCMKTS:BSEM) last issued its quarterly earnings results on Monday, August 12th. The company reported 0.30 earnings per share for the quarter, topping analysts’ consensus estimates of 0.12 by 0.18. The company had revenue of 74.49 million during the quarter, compared to analyst estimates of 43.99 million. Equities analysts anticipate that BioStem Technologies will post 1.13 EPS for the current year.

BioStem Technologies Company Profile

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.